Living longer but above all living better is a fundamental issue for the vast majority. Investment per capita in health products and services is increasing practically everywhere in the world and there is no indication that the trend will reverse.
In order to satisfy this demand, the sector has developed completely new goods and services, opening up market niches with great acceptance. On the other hand, this dynamism has not been accompanied by the emergence of new actors, not at least to the same degree. The strong regulation of the sector, the inertia of established relationships and the technical complexity of the activity, represent a significant barrier to entry, affecting competition and consolidating margins that are clearly higher than in other sectors. Aware of all this, Da Gayo Inversiones took on the challenge of entering the sector. First, a great effort was made to obtain the necessary permits. Thus, the license for the importation and distribution of health products was obtained, in order to later achieve training for intermediation in the sale of medicines. Next, relationships were established with leading laboratories and distributors in the market, this being a particularly complex task. The scrupulous fulfillment of the commitments acquired in a period of special difficulty, has allowed closer ties with the main players, building in record time a key confidence in the sector that otherwise would have been impossible. The short-term objective is to further increase the number of operations and their average billing, as well as to incorporate new product segments to the already extensive catalogue.
Almacén homologado por la AEMPS de BSD Pharma en Madrid, partner estratégico de Da Gayo